Alembic receives USFDA final approval for Ticagrelor Tablets, 90 mg and tentative approval for Ticagrelor Tablets, 60 mg
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
These observations are procedural in nature and none of them are related to data integrity
The Q1 2025 also witnessed a successful launch of Allegra D
Breztri is an inhaled triple-combination therapy approved for the treatment of chronic obstructive pulmonary disease
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
Alembic Pharmaceuticals commissions new facility at Pithampur
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
ekincare has raised a total funding of $22M since 2015 till date
The inspection concluded with 6 observations and none of them were related to Data Integrity
Subscribe To Our Newsletter & Stay Updated